false
OasisLMS
zh-CN,zh-TW,en,fr,de,hi,ja,ko,pt,es
Catalog
Clinical Implications of Lipodystrophy
Clinical Implications of Lipodystrophy
Clinical Implications of Lipodystrophy
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video is a webinar presented by an endocrinologist named Suman Srinivasa. She is speaking on the topic of lipodystrophy. In the webinar, she discusses the role of fat in the body, different types of lipodystrophies, including generalized and partial lipodystrophies, and the potential metabolic consequences. She also explores the contributors to HIV-associated lipodystrophy and treatment strategies, such as metropolitane and tisamorelin. The speaker provides an overview of adipose tissue and its classification, as well as the different depots in the body, such as subcutaneous and visceral fat. She also explains the functions of adipocytes and their role in energy storage and release. The webinar includes information on the diagnosis of lipodystrophy, including physical examinations, laboratory tests, and genetic testing. Treatment options, including diet, exercise, and medications, are discussed, with a focus on leptin replacement therapy in generalized lipodystrophy and the use of tisamorelin in HIV lipodystrophy. The speaker also describes the potential benefits of metformin and glitazones in reducing insulin resistance. Finally, the webinar touches on the potential benefits of growth hormone and growth hormone-releasing hormone analogs in treating lipodystrophies. Overall, the webinar provides a comprehensive overview of lipodystrophy, its causes, diagnosis, and treatment options.
Keywords
Lipodystrophy
Fat
HIV-associated lipodystrophy
Metropolitane
Tisamorelin
Adipose tissue
Diagnosis
Leptin replacement therapy
Insulin resistance
Treatment options
×